Syncom Formulations (India) Ltd
NSE:SYNCOMF
Syncom Formulations (India) Ltd
Note Receivable
Syncom Formulations (India) Ltd
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Syncom Formulations (India) Ltd
NSE:SYNCOMF
|
Note Receivable
₹6.7m
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Note Receivable
₹3.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Note Receivable
₹5.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
59%
|
CAGR 10-Years
7%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Note Receivable
₹2.6B
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-21%
|
|
|
Lupin Ltd
NSE:LUPIN
|
Note Receivable
₹504.1m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-16%
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Note Receivable
₹2.4B
|
CAGR 3-Years
28%
|
CAGR 5-Years
25%
|
CAGR 10-Years
2%
|
|
Syncom Formulations (India) Ltd
Glance View
Syncom Formulation India Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Indore, Madhya Pradesh. The firm manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquid orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments and inhalers. Its segments include Pharmaceuticals Drugs & Formulations, Trading of Commodities and Renting of property. Its product categories include tablets, capsules, ointments, injections, liquid-oral and packaging variants. The company offers various products, including generics, alpha adrenoceptor agonist, analgesic, antipyretic, anti-inflammatory, anti-ulcer agents, antibiotic, antidepressant, antiviral, cephelo sporins, cortico steroid, estrogen, cough suppressant and sedative anticonvulsant, among others. The firm operates in more than 15 countries across the world.
See Also
What is Syncom Formulations (India) Ltd's Note Receivable?
Note Receivable
6.7m
INR
Based on the financial report for Mar 31, 2025, Syncom Formulations (India) Ltd's Note Receivable amounts to 6.7m INR.
What is Syncom Formulations (India) Ltd's Note Receivable growth rate?
Note Receivable CAGR 3Y
25%
Over the last year, the Note Receivable growth was 28%. The average annual Note Receivable growth rates for Syncom Formulations (India) Ltd have been 25% over the past three years .
